TCM Biotech International Corp. (TPEX:4169)

TCM Biotech International Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	232.98	504.13	89.85	58.26	34.27
Short-Term Investments	300	-	0.09	-	-
Cash & Short-Term Investments	532.98	504.13	89.94	58.26	34.27
Cash Growth	5.72%	460.55%	54.38%	70.01%	17.11%
Accounts Receivable	139.96	259.08	225.83	190.68	167.95
Other Receivables	1.69	3.61	3.94	0.03	0.09
Receivables	141.65	262.69	229.77	190.71	168.05
Inventory	128.93	208.36	193.25	203.33	207.39
Prepaid Expenses	8.27	4.46	0.65	17.08	18.46
Other Current Assets	0.15	1.51	0.13	0.74	0.46
Total Current Assets	811.98	981.15	513.74	470.11	428.62
Property, Plant & Equipment	291.91	293.71	301.74	285.36	291.91
Long-Term Investments	30	-	-	-	-
Other Intangible Assets	20.72	8.01	10.24	13.21	15.2
Long-Term Deferred Tax Assets	1.02	0.98	1.63	4.2	4.88
Long-Term Deferred Charges	-	15.66	15.66	16.26	14.59
Other Long-Term Assets	26.73	23.41	19.87	30.92	17.07
Total Assets	1,182	1,323	862.87	820.06	772.26
Accounts Payable	20.69	64.53	88.81	55.54	42.53
Accrued Expenses	-	50.18	52.01	36.84	35.41
Short-Term Debt	-	44	44	44	-
Current Portion of Long-Term Debt	-	5.19	10.44	9.21	9.6
Current Portion of Leases	3.72	1.68	2.95	1.84	2.16
Current Income Taxes Payable	4.03	2.59	2.35	-	3.51
Current Unearned Revenue	2.84	2.25	2.76	5.12	3.8
Other Current Liabilities	50.62	27.96	21.54	23.38	19.19
Total Current Liabilities	81.9	198.38	224.84	175.93	116.21
Long-Term Debt	28.54	59.69	93.58	104.51	113.89
Long-Term Leases	8.16	4.81	6.49	1.45	3.29
Long-Term Unearned Revenue	3.23	3.23	-	18.2	18.2
Long-Term Deferred Tax Liabilities	0	-	0.01	-	-
Other Long-Term Liabilities	1.46	0.27	0.27	0.16	0.16
Total Liabilities	123.28	267.88	326.2	301.84	255.02
Common Stock	590.49	590.49	475.92	475.92	475.92
Additional Paid-In Capital	415.77	415.77	13.82	13.82	12.09
Retained Earnings	52.87	48.85	47.04	28.47	42.34
Treasury Stock	-	-	-	-	-13.09
Comprehensive Income & Other	-0.05	-0.07	-0.11	0.01	-0.02
Shareholders' Equity	1,059	1,055	536.67	518.22	517.24
Total Liabilities & Equity	1,182	1,323	862.87	820.06	772.26
Total Debt	40.42	115.38	157.46	161	128.94
Net Cash (Debt)	492.57	388.76	-67.52	-102.75	-94.67
Net Cash Growth	26.70%	-	-	-	-
Net Cash Per Share	8.44	7.33	-1.38	-2.11	-1.95
Filing Date Shares Outstanding	57.67	59.05	49.05	49.05	48.43
Total Common Shares Outstanding	57.67	59.05	49.05	49.05	48.43
Working Capital	730.08	782.78	288.9	294.18	312.41
Book Value Per Share	18.36	17.87	10.94	10.57	10.68
Tangible Book Value	1,038	1,047	526.43	505.01	502.04
Tangible Book Value Per Share	18.00	17.73	10.73	10.30	10.37
Land	-	83.08	83.08	83.08	83.08
Buildings	-	196.97	196.6	194.3	192.59
Machinery	-	101.48	93.09	77.69	71.78
Leasehold Improvements	-	10.33	9.76	3.41	2.72

Source: S&P Global Market Intelligence. Standard template. Financial Sources.